Dr. William Stohl of the University of Southern California discusses the relationships among various parts of the immune system and their role in triggering lupus.
Biomarkers for Lupus Diagnosis and Disease Activity
Dr. Michael Ward, an investigator with the intramural research program for the National Institute of Arthritis and Musculoskeletal and Skin Diseases, reviews how biomarkers are used to diagnose lupus and monitor disease activity. Validated biomarkers are essential to having the tools needed to improve the diagnosis and treatment of lupus, develop screening tests for the disease, and speed development and approval of new, safe and more tolerable therapies for lupus.
Dr. Gregg Silverman discusses B-cells and how they contribute to the development of lupus and offers insight on the future direction of lupus research.